A Phase 1, Single Dose, Randomized, Cross-Over Absolute Bioavailability Study In Healthy Volunteers Comparing Oral To Intravenous Administration Of Crizotinib (PF-02341066).
Phase of Trial: Phase I
Latest Information Update: 02 Jul 2014
At a glance
- Drugs Crizotinib (Primary) ; Crizotinib (Primary)
- Indications Cancer; Non-small cell lung cancer
- Focus Pharmacokinetics
- 09 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 27 Jul 2010 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History